Maxime Brunet

962 total citations · 1 hit paper
11 papers, 226 citations indexed

About

Maxime Brunet is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Maxime Brunet has authored 11 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Maxime Brunet's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (3 papers) and Lung Cancer Research Studies (3 papers). Maxime Brunet is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (3 papers) and Lung Cancer Research Studies (3 papers). Maxime Brunet collaborates with scholars based in France and United States. Maxime Brunet's co-authors include Antoîne Italiano, Alban Bessede, Emmanuel Khalifa, François Le Loarer, Christophe Rey, Isabelle Soubeyran, Jean‐Yves Scoazec, Sylvestre Le Moulec, Jean‐Philippe Guégan and Benjamin Besse and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Frontiers in Oncology.

In The Last Decade

Maxime Brunet

10 papers receiving 226 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures

2025 18 citations Florent Peyraud, Lucile Vanhersecke et al. Cell Reports Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maxime Brunet France	5	136	113	70	47	30	11	226
Dong‐Chun Hong China	8	98 0.7×	50 0.4×	104 1.5×	62 1.3×	4 0.1×	15	226
Christoph Baran Germany	10	110 0.8×	56 0.5×	167 2.4×	29 0.6×	20 0.7×	14	334
R. Dummer Switzerland	5	190 1.4×	108 1.0×	60 0.9×	36 0.8×	4 0.1×	17	239
Rana Harb United States	7	116 0.9×	63 0.6×	47 0.7×	152 3.2×	3 0.1×	9	211
Kazushige Koike Japan	5	165 1.2×	80 0.7×	49 0.7×	65 1.4×	11 0.4×	10	260
Atsushi Kyan Japan	7	37 0.3×	51 0.5×	110 1.6×	44 0.9×	6 0.2×	17	189
Mara Epstein United States	4	78 0.6×	31 0.3×	59 0.8×	49 1.0×	7 0.2×	5	181
Michael Mints Sweden	9	84 0.6×	47 0.4×	151 2.2×	35 0.7×	6 0.2×	19	295
Jennifer Perez France	5	40 0.3×	34 0.3×	123 1.8×	71 1.5×	9 0.3×	5	236
Osamu Kawai Japan	7	288 2.1×	235 2.1×	49 0.7×	82 1.7×	2 0.1×	10	374

Countries citing papers authored by Maxime Brunet

Since Specialization

Citations

This map shows the geographic impact of Maxime Brunet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Brunet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Brunet more than expected).

Fields of papers citing papers by Maxime Brunet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Brunet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Brunet. The network helps show where Maxime Brunet may publish in the future.

Co-authorship network of co-authors of Maxime Brunet

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Brunet. A scholar is included among the top collaborators of Maxime Brunet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Brunet. Maxime Brunet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Peyraud, Florent, Jean‐Philippe Guégan, Lucile Vanhersecke, et al.. (2025). Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside. Med. 6(1). 100546–100546. 13 indexed citations

Peyraud, Florent, Lucile Vanhersecke, Jean‐Michel Coindre, et al.. (2025). Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures. Cell Reports Medicine. 6(2). 101934–101934. 18 indexed citations breakdown →

Peyraud, Florent, Jean‐Philippe Guégan, Lucile Vanhersecke, et al.. (2024). Abstract 7471: Cancer-associated fibroblasts drive T cell infiltration and resistance to immunotherapy in non-small cell lung cancer with mature tertiary lymphoid structures. Cancer Research. 84(6_Supplement). 7471–7471. 1 indexed citations

Cousin, Sophie, Arnaud Bayle, Étienne Rouleau, et al.. (2024). Abstract LB104: Tumor fraction as a predictive factor of outcome in patients referred for oncology early phase clinical trials: Analyses of two precision medicine studies. Cancer Research. 84(7_Supplement). LB104–LB104.

Vanhersecke, Lucile, Antoine Bougoüin, Amandine Crombé, et al.. (2023). Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers. Laboratory Investigation. 103(5). 100063–100063. 49 indexed citations

Peyraud, Florent, Jean‐Philippe Guégan, Lucile Vanhersecke, et al.. (2023). Abstract 6767: Cancer-associated fibroblasts promote T-cell exclusion and resistance to immunotherapy in non-small cell lung cancer with tertiary lymphoid structures. Cancer Research. 83(7_Supplement). 6767–6767. 1 indexed citations

Brunet, Maxime, et al.. (2023). Abstract 2361: Prevalence of mature tertiary lymphoid structures and association with tumor mutational burden in patients with solid tumors. Cancer Research. 83(7_Supplement). 2361–2361. 2 indexed citations

Larroquette, Mathieu, Jean‐Philippe Guégan, Benjamin Besse, et al.. (2022). Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1/PD-L1 antibodies. Journal for ImmunoTherapy of Cancer. 10(5). e003890–e003890. 105 indexed citations

Peyraud, Florent, Jean‐Philippe Guégan, Sophie Cousin, et al.. (2022). Identification of super-exhausted T cells: A novel population predictive of response to immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). 2596–2596. 2 indexed citations

10.

Brunet, Maxime, et al.. (2022). Fast replanning of a lower-limb exoskeleton trajectories for rehabilitation. 2022 IEEE 61st Conference on Decision and Control (CDC). 2039–2046. 2 indexed citations

11.

Brunet, Maxime, Emmanuel Khalifa, & Antoîne Italiano. (2019). Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma. Frontiers in Oncology. 9. 1204–1204. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact